Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
Organon & Co. roi for the quarter ending 2025-03-31 was 7.90%, a 33.92% decline year-over-year.
Organon & Co. roi for the quarter ending 2024-12-31 was 9.24%, a 21.52% decline year-over-year.
Organon & Co. roi for the quarter ending 2024-09-30 was 14.08%, a 94.07% increase year-over-year.
Organon & Co. roi for the quarter ending 2024-06-30 was 11.36%, a 23.21% increase year-over-year.
Organon & Co. roi for fiscal 2024 was 9.24%, a 21.52% decline from fiscal 2023.
Organon & Co. roi for fiscal 2023 was 11.77%, a 2.97% increase from fiscal 2022.
Organon & Co. roi for fiscal 2022 was 11.43%, a 35.47% decline from fiscal 2021.
Organon & Co. roi for fiscal 2021 was 17.72%, a 55.01% decline from fiscal 2020.